US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 44.585
  • +0.805+1.84%
Trading Dec 16 14:06 ET
3.81BMarket Cap-15.98P/E (TTM)

CRISPR Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
11.26%1.94B
13.21%2B
11.95%2.11B
-6.70%1.69B
-6.70%1.69B
-8.24%1.74B
-14.39%1.77B
-15.22%1.88B
-23.70%1.82B
-23.70%1.82B
-Cash and cash equivalents
-57.24%225.67M
8.92%484.47M
105.40%707.43M
83.82%389.48M
83.82%389.48M
6.80%527.77M
-10.48%444.8M
-49.64%344.41M
-77.04%211.89M
-77.04%211.89M
-Short-term investments
41.08%1.71B
14.65%1.52B
-8.97%1.4B
-18.66%1.3B
-18.66%1.3B
-13.54%1.21B
-15.63%1.32B
0.09%1.54B
10.12%1.6B
10.12%1.6B
Receivables
--0
--0
--0
--200M
--200M
----
105,960.61%70M
----
--0
--0
-Accounts receivable
--0
--0
--0
--200M
--200M
----
105,960.61%70M
----
--0
--0
Other current assets
-60.28%8.25M
-59.07%8.79M
-53.63%11.5M
-61.85%14.39M
-61.85%14.39M
--20.76M
--21.47M
--24.8M
-0.97%37.71M
-0.97%37.71M
Total current assets
10.41%1.94B
8.11%2.01B
11.09%2.12B
2.97%1.91B
2.97%1.91B
-8.91%1.76B
-11.75%1.86B
-15.60%1.91B
-23.35%1.85B
-23.35%1.85B
Non current assets
Net PPE
-8.81%284.83M
-8.46%291.57M
-5.40%298.51M
-4.56%305.94M
-4.56%305.94M
-4.66%312.34M
-4.04%318.52M
-4.09%315.54M
2.73%320.56M
2.73%320.56M
-Gross PPE
-2.29%352.62M
-2.13%354.64M
0.66%356.76M
1.41%359.37M
1.41%359.37M
1.49%360.88M
-5.40%362.34M
-4.94%354.41M
1.30%354.39M
1.30%354.39M
-Accumulated depreciation
-39.64%-67.79M
-43.94%-63.07M
-49.87%-58.25M
-57.94%-53.43M
-57.94%-53.43M
-73.58%-48.55M
14.23%-43.82M
11.32%-38.87M
10.51%-33.83M
10.51%-33.83M
Goodwill and other intangible assets
--0
--0
-96.49%2K
-77.46%16K
-77.46%16K
-64.29%30K
-56.12%43K
-49.11%57K
-43.20%71K
-43.20%71K
Investments and advances
--0
128.85%11.22M
--0
-96.29%1.97M
-96.29%1.97M
--0
-41.60%4.9M
--6.32M
--53.13M
--53.13M
Other non current assets
97.53%27.41M
90.79%26.66M
44.26%20.88M
-16.65%13.57M
-16.65%13.57M
-12.20%13.88M
-12.02%13.97M
-12.01%14.48M
-26.70%16.28M
-26.70%16.28M
Total non current assets
-4.29%312.24M
-2.37%329.45M
-5.06%319.39M
-17.57%321.49M
-17.57%321.49M
-22.44%326.24M
-5.29%337.44M
-2.65%336.4M
16.65%390.03M
16.65%390.03M
Total assets
8.11%2.26B
6.50%2.34B
8.67%2.44B
-0.60%2.23B
-0.60%2.23B
-11.33%2.09B
-10.81%2.2B
-13.88%2.24B
-18.49%2.24B
-18.49%2.24B
Liabilities
Current liabilities
Payables
-37.65%16.42M
-64.80%9.91M
-61.10%17.67M
39.99%38.59M
39.99%38.59M
-27.64%26.33M
-3.60%28.15M
52.85%45.43M
77.37%27.56M
77.37%27.56M
-accounts payable
-40.43%15.58M
-65.74%9.45M
-63.54%16.46M
39.08%38.15M
39.08%38.15M
-18.57%26.15M
9.29%27.59M
66.55%45.15M
85.12%27.43M
85.12%27.43M
-Total tax payable
376.14%838K
-18.64%454K
342.12%1.21M
224.44%438K
224.44%438K
-95.88%176K
-85.88%558K
-89.53%273K
-81.35%135K
-81.35%135K
Current accrued expenses
-28.91%47.2M
2.28%91.88M
-10.74%76.43M
-41.64%45.34M
-41.64%45.34M
-35.50%66.41M
9.26%89.84M
17.90%85.63M
-14.64%77.68M
-14.64%77.68M
Current debt and capital lease obligation
12.55%16.88M
10.91%16.45M
1.75%15.99M
-1.37%15.63M
-1.37%15.63M
33.22%15M
79.42%14.83M
41.90%15.72M
30.30%15.84M
30.30%15.84M
-Current capital lease obligation
12.55%16.88M
10.91%16.45M
1.75%15.99M
-1.37%15.63M
-1.37%15.63M
33.22%15M
79.42%14.83M
41.90%15.72M
30.30%15.84M
30.30%15.84M
Current deferred liabilities
28.09%4.48M
--4.76M
--4.07M
--4.11M
--4.11M
--3.5M
----
----
--0
--0
Other current liabilities
--4.82M
24,020.00%4.82M
24,020.00%4.82M
25,605.00%5.14M
25,605.00%5.14M
----
-92.59%20K
-92.59%20K
-88.30%20K
-88.30%20K
Current liabilities
-19.26%89.81M
-3.77%127.82M
-18.94%118.99M
-10.17%108.79M
-10.17%108.79M
-26.27%111.23M
10.74%132.84M
29.11%146.79M
1.02%121.11M
1.02%121.11M
Non current liabilities
Long term debt and capital lease obligation
-7.03%210.66M
-6.72%214.85M
-2.50%218.94M
-2.27%223.01M
-2.27%223.01M
-1.87%226.59M
-1.63%230.34M
-1.47%224.55M
7.19%228.18M
7.19%228.18M
-Long term capital lease obligation
-7.03%210.66M
-6.72%214.85M
-2.50%218.94M
-2.27%223.01M
-2.27%223.01M
-1.87%226.59M
-1.63%230.34M
-1.47%224.55M
7.19%228.18M
7.19%228.18M
Non current deferred liabilities
-22.12%12.32M
2.11%12.58M
9.88%13.54M
13.71%14.01M
13.71%14.01M
28.40%15.82M
0.00%12.32M
0.00%12.32M
0.00%12.32M
0.00%12.32M
Other non current liabilities
-31.83%3.68M
-33.52%3.65M
-37.66%3.62M
-83.95%958K
-83.95%958K
1.51%5.39M
-9.98%5.48M
-20.94%5.8M
-18.67%5.97M
-18.67%5.97M
Total non current liabilities
-8.53%226.66M
-6.88%231.08M
-2.71%236.09M
-3.45%237.98M
-3.45%237.98M
-0.29%247.8M
-1.75%248.15M
-1.97%242.67M
5.99%246.47M
5.99%246.47M
Total liabilities
-11.86%316.47M
-5.80%358.9M
-8.83%355.08M
-5.66%346.77M
-5.66%346.77M
-10.11%359.04M
2.27%380.99M
7.81%389.47M
4.30%367.58M
4.30%367.58M
Shareholders'equity
Share capital
8.40%2.68M
7.72%2.67M
8.40%2.66M
2.29%2.5M
2.29%2.5M
1.77%2.48M
2.23%2.47M
1.87%2.45M
2.09%2.44M
2.09%2.44M
-common stock
8.40%2.68M
7.72%2.67M
8.40%2.66M
2.29%2.5M
2.29%2.5M
1.77%2.48M
2.23%2.47M
1.87%2.45M
2.09%2.44M
2.09%2.44M
Retained earnings
-22.00%-1.33B
-27.21%-1.24B
-24.15%-1.12B
-18.16%-999.7M
-18.16%-999.7M
-48.07%-1.09B
-74.15%-976.9M
-139.69%-899.16M
-331.87%-846.09M
-331.87%-846.09M
Paid-in capital
15.38%3.26B
15.16%3.22B
15.87%3.2B
5.24%2.88B
5.24%2.88B
4.13%2.82B
4.86%2.8B
4.80%2.76B
5.26%2.73B
5.26%2.73B
Less: Treasury stock
-1.59%62K
-1.59%62K
-1.59%62K
-1.59%62K
-1.59%62K
0.00%63K
0.00%63K
0.00%63K
0.00%63K
0.00%63K
Gains losses not affecting retained earnings
255.44%10.57M
67.68%-2.88M
83.47%-1.55M
112.23%1.91M
112.23%1.91M
69.47%-6.8M
56.21%-8.91M
44.43%-9.39M
-208.80%-15.65M
-208.80%-15.65M
Total stockholders'equity
12.26%1.94B
9.08%1.98B
12.35%2.08B
0.39%1.88B
0.39%1.88B
-11.57%1.73B
-13.14%1.82B
-17.37%1.85B
-21.84%1.88B
-21.84%1.88B
Total equity
12.26%1.94B
9.08%1.98B
12.35%2.08B
0.39%1.88B
0.39%1.88B
-11.57%1.73B
-13.14%1.82B
-17.37%1.85B
-21.84%1.88B
-21.84%1.88B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 11.26%1.94B13.21%2B11.95%2.11B-6.70%1.69B-6.70%1.69B-8.24%1.74B-14.39%1.77B-15.22%1.88B-23.70%1.82B-23.70%1.82B
-Cash and cash equivalents -57.24%225.67M8.92%484.47M105.40%707.43M83.82%389.48M83.82%389.48M6.80%527.77M-10.48%444.8M-49.64%344.41M-77.04%211.89M-77.04%211.89M
-Short-term investments 41.08%1.71B14.65%1.52B-8.97%1.4B-18.66%1.3B-18.66%1.3B-13.54%1.21B-15.63%1.32B0.09%1.54B10.12%1.6B10.12%1.6B
Receivables --0--0--0--200M--200M----105,960.61%70M------0--0
-Accounts receivable --0--0--0--200M--200M----105,960.61%70M------0--0
Other current assets -60.28%8.25M-59.07%8.79M-53.63%11.5M-61.85%14.39M-61.85%14.39M--20.76M--21.47M--24.8M-0.97%37.71M-0.97%37.71M
Total current assets 10.41%1.94B8.11%2.01B11.09%2.12B2.97%1.91B2.97%1.91B-8.91%1.76B-11.75%1.86B-15.60%1.91B-23.35%1.85B-23.35%1.85B
Non current assets
Net PPE -8.81%284.83M-8.46%291.57M-5.40%298.51M-4.56%305.94M-4.56%305.94M-4.66%312.34M-4.04%318.52M-4.09%315.54M2.73%320.56M2.73%320.56M
-Gross PPE -2.29%352.62M-2.13%354.64M0.66%356.76M1.41%359.37M1.41%359.37M1.49%360.88M-5.40%362.34M-4.94%354.41M1.30%354.39M1.30%354.39M
-Accumulated depreciation -39.64%-67.79M-43.94%-63.07M-49.87%-58.25M-57.94%-53.43M-57.94%-53.43M-73.58%-48.55M14.23%-43.82M11.32%-38.87M10.51%-33.83M10.51%-33.83M
Goodwill and other intangible assets --0--0-96.49%2K-77.46%16K-77.46%16K-64.29%30K-56.12%43K-49.11%57K-43.20%71K-43.20%71K
Investments and advances --0128.85%11.22M--0-96.29%1.97M-96.29%1.97M--0-41.60%4.9M--6.32M--53.13M--53.13M
Other non current assets 97.53%27.41M90.79%26.66M44.26%20.88M-16.65%13.57M-16.65%13.57M-12.20%13.88M-12.02%13.97M-12.01%14.48M-26.70%16.28M-26.70%16.28M
Total non current assets -4.29%312.24M-2.37%329.45M-5.06%319.39M-17.57%321.49M-17.57%321.49M-22.44%326.24M-5.29%337.44M-2.65%336.4M16.65%390.03M16.65%390.03M
Total assets 8.11%2.26B6.50%2.34B8.67%2.44B-0.60%2.23B-0.60%2.23B-11.33%2.09B-10.81%2.2B-13.88%2.24B-18.49%2.24B-18.49%2.24B
Liabilities
Current liabilities
Payables -37.65%16.42M-64.80%9.91M-61.10%17.67M39.99%38.59M39.99%38.59M-27.64%26.33M-3.60%28.15M52.85%45.43M77.37%27.56M77.37%27.56M
-accounts payable -40.43%15.58M-65.74%9.45M-63.54%16.46M39.08%38.15M39.08%38.15M-18.57%26.15M9.29%27.59M66.55%45.15M85.12%27.43M85.12%27.43M
-Total tax payable 376.14%838K-18.64%454K342.12%1.21M224.44%438K224.44%438K-95.88%176K-85.88%558K-89.53%273K-81.35%135K-81.35%135K
Current accrued expenses -28.91%47.2M2.28%91.88M-10.74%76.43M-41.64%45.34M-41.64%45.34M-35.50%66.41M9.26%89.84M17.90%85.63M-14.64%77.68M-14.64%77.68M
Current debt and capital lease obligation 12.55%16.88M10.91%16.45M1.75%15.99M-1.37%15.63M-1.37%15.63M33.22%15M79.42%14.83M41.90%15.72M30.30%15.84M30.30%15.84M
-Current capital lease obligation 12.55%16.88M10.91%16.45M1.75%15.99M-1.37%15.63M-1.37%15.63M33.22%15M79.42%14.83M41.90%15.72M30.30%15.84M30.30%15.84M
Current deferred liabilities 28.09%4.48M--4.76M--4.07M--4.11M--4.11M--3.5M----------0--0
Other current liabilities --4.82M24,020.00%4.82M24,020.00%4.82M25,605.00%5.14M25,605.00%5.14M-----92.59%20K-92.59%20K-88.30%20K-88.30%20K
Current liabilities -19.26%89.81M-3.77%127.82M-18.94%118.99M-10.17%108.79M-10.17%108.79M-26.27%111.23M10.74%132.84M29.11%146.79M1.02%121.11M1.02%121.11M
Non current liabilities
Long term debt and capital lease obligation -7.03%210.66M-6.72%214.85M-2.50%218.94M-2.27%223.01M-2.27%223.01M-1.87%226.59M-1.63%230.34M-1.47%224.55M7.19%228.18M7.19%228.18M
-Long term capital lease obligation -7.03%210.66M-6.72%214.85M-2.50%218.94M-2.27%223.01M-2.27%223.01M-1.87%226.59M-1.63%230.34M-1.47%224.55M7.19%228.18M7.19%228.18M
Non current deferred liabilities -22.12%12.32M2.11%12.58M9.88%13.54M13.71%14.01M13.71%14.01M28.40%15.82M0.00%12.32M0.00%12.32M0.00%12.32M0.00%12.32M
Other non current liabilities -31.83%3.68M-33.52%3.65M-37.66%3.62M-83.95%958K-83.95%958K1.51%5.39M-9.98%5.48M-20.94%5.8M-18.67%5.97M-18.67%5.97M
Total non current liabilities -8.53%226.66M-6.88%231.08M-2.71%236.09M-3.45%237.98M-3.45%237.98M-0.29%247.8M-1.75%248.15M-1.97%242.67M5.99%246.47M5.99%246.47M
Total liabilities -11.86%316.47M-5.80%358.9M-8.83%355.08M-5.66%346.77M-5.66%346.77M-10.11%359.04M2.27%380.99M7.81%389.47M4.30%367.58M4.30%367.58M
Shareholders'equity
Share capital 8.40%2.68M7.72%2.67M8.40%2.66M2.29%2.5M2.29%2.5M1.77%2.48M2.23%2.47M1.87%2.45M2.09%2.44M2.09%2.44M
-common stock 8.40%2.68M7.72%2.67M8.40%2.66M2.29%2.5M2.29%2.5M1.77%2.48M2.23%2.47M1.87%2.45M2.09%2.44M2.09%2.44M
Retained earnings -22.00%-1.33B-27.21%-1.24B-24.15%-1.12B-18.16%-999.7M-18.16%-999.7M-48.07%-1.09B-74.15%-976.9M-139.69%-899.16M-331.87%-846.09M-331.87%-846.09M
Paid-in capital 15.38%3.26B15.16%3.22B15.87%3.2B5.24%2.88B5.24%2.88B4.13%2.82B4.86%2.8B4.80%2.76B5.26%2.73B5.26%2.73B
Less: Treasury stock -1.59%62K-1.59%62K-1.59%62K-1.59%62K-1.59%62K0.00%63K0.00%63K0.00%63K0.00%63K0.00%63K
Gains losses not affecting retained earnings 255.44%10.57M67.68%-2.88M83.47%-1.55M112.23%1.91M112.23%1.91M69.47%-6.8M56.21%-8.91M44.43%-9.39M-208.80%-15.65M-208.80%-15.65M
Total stockholders'equity 12.26%1.94B9.08%1.98B12.35%2.08B0.39%1.88B0.39%1.88B-11.57%1.73B-13.14%1.82B-17.37%1.85B-21.84%1.88B-21.84%1.88B
Total equity 12.26%1.94B9.08%1.98B12.35%2.08B0.39%1.88B0.39%1.88B-11.57%1.73B-13.14%1.82B-17.37%1.85B-21.84%1.88B-21.84%1.88B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.